danazcomd Profile Banner
Diego Anazco, MD Profile
Diego Anazco, MD

@danazcomd

Followers
757
Following
2K
Media
27
Statuses
514

PGY-2 @UTSWInternalMed | Research Collaborator @MayoClinicGIHep | MD @USFQ_Ecuador 🇪🇨 | Aspiring GI | #COYG 🔴 | ⚽️ 🏓🧉🤿

Joined July 2012
Don't wanna be here? Send us removal request.
@danazcomd
Diego Anazco, MD
2 years
Beyond thrilled to have matched at my dream program! @UTSWInternalMed @UTSWIMchief Forever grateful for the support from my family, soon-to-be wife, friends, and exceptional mentors @dr_aac @Dr_RADillingham @Pablo_delaC @MDanielaHurtado Dallas, here we go! 🚀 #Match2024
21
12
315
@LuisAntonioDiaz
Luis Antonio Díaz, MD
1 month
Don’t miss out on the next @alehlatam @AASLDtweets webinar: Hot Topics in ALD and MetALD. Coordinated by @juanpabloarab We will have excellent speakers @FATIMAHiguera8 @BlaneyMD @geneyim and live translation! 🔗Registration link: https://t.co/ZpAnZNoX67
1
11
32
@NEJM
NEJM
1 month
Original Article: Deferring Arterial Catheterization in Critically Ill Patients with Shock (EVERDAC trial) https://t.co/N5ou9POC0r   Editorial: A Less Invasive Approach to Intensive Care https://t.co/l5fexdtzZX #CriticalCare
0
33
126
@ebtapper
Elliot Tapper
1 month
Everyone needs to see these results And a word about Alistair O’Brien. Magnetic on stage and The most important trialist in all of liverland. An inspiration #tlm25
@pgholam
Pierre Gholam
1 month
ASEPTIC trial RCT #TLM25 LB cotrimoxazole vs placebo for primary prophylaxis of SBP shows no difference in survival outcome. You could have knocked me out with a feather… We should stop doing SBP primary prophylaxis. No exceptions. #livertwitter
3
13
79
@Cell_Metabolism
Cell Metabolism
1 month
When more is not worse: Genetic subtypes of obesity challenge conventional risk paradigms https://t.co/tnetaAynNV
1
16
46
@danazcomd
Diego Anazco, MD
1 month
Just wrapped up an incredible #ObesityWeek in Atlanta! 🎉 Honored to chair my first session — a milestone made possible thanks to the guidance of amazing mentors. Grateful for the inspiring discussions and chance to reconnect with friends! @ObesitySociety @UTSWInternalMed
3
1
17
@Arsenal
Arsenal
2 months
The first Ecuadorian in our history 🇪🇨 Congratulations on making your Premier League debut, Piero ❤️
189
3K
28K
@rabataller
Ramon Bataller
2 months
The 2025 BCLC update on liver cancer management is here! Key highlights: - Updated HCC diagnosis & staging - New treatment decision algorithms - Insights on using novel checkpoint inhibitors https://t.co/bK7pW2JfKq
3
188
375
@ebtapper
Elliot Tapper
2 months
Ascites management
5
69
259
@scottisaacsmd
Scott Isaacs
2 months
Tirzepatide leads to weight loss in people with obesity due to MC4R deficiency. https://t.co/NYhci0sYDh
6
63
201
@TCotterMD
Thomas G. Cotter, MD MS
2 months
Trailblazer @DrGlendaRamos — 2025 @myESMO Oncologist of the Year ✅1st female oncologist in 🇪🇨 ✅Medicine Chief @SolcaGuayaquil ✅ 30+ yrs advancing cancer care & training ✅Medication access champion ✅”Don’t Give Cancer a Chance” campaign ✅National media 🗞️ @eluniversocom
3
4
21
@AndreeFrans
Frans Serpa
2 months
Celebrating IMG recognition week with our annual dinner at Dr. Kazi’s home — lucky to be surrounded by so many talented physicians from all over the world in one of the largest and most distinguished residency programs in the U.S. @UTSWInternalMed @UTSWIMchief
1
5
77
@ebtapper
Elliot Tapper
2 months
Osteoporosis and Fractures are common in cirrhosis But sadly treatment is not! Let’s change that This trial, though small, suggests Denosumab or bisphosphonates are both helpful https://t.co/noO23DLBGe
3
26
69
@m_alhasan9
Mohammed Al-Hasan
3 months
Hi #MedTwitter ! I'm Mohammed Al-Hasan, a @UJ_MED graduate and a current postdoc research fellow at @UTSWMedCenter. Excited to be applying for #internalmedicine #Match2026. My interests? sports ⚽️🥋, movies 🎥, and Liver research 🔬. Let's connect! AAMC ID: 15735586
10
6
93
@Eliasrady_MD
Elias Rady, MD
3 months
Hi #MedTwitter! I’m Elias Rady, an @AUB_Lebanon graduate and current postdoctoral research fellow @UTSWMedCenter. Interested in Hepatology and academic medicine. I’m thrilled to be applying for #InternalMedicine #Match2026. AAMC ID: 16731155
22
8
130
@VictorCuenca3
Víctor Cuenca Narváez
3 months
Hi #MedTwitter! I’m Victor Cuenca Narvaez 🇪🇨 Research Fellow at @MayoClinic applying to #InternalMedicine. Passionate about community outreach, research, and med ed. Outside medicine I love running, reading, and exploring new places. Let's connect! AAMC ID 16096461 #Match2026
8
22
115
@Ahmed_Eissa_G
Ahmed Eissa Garces
3 months
Hello #MedTwitter! I’m Ahmed Eissa-Garces 🇪🇨🇪🇬 postdoc research fellow at @BIDMCSurgery | @HarvardMed via @IRI_program, applying for #GeneralSurgery in this #Match2026. AAMC ID: 16067336 Passionate about surgery, research, and yes… finding the world’s best burger 🍔
14
27
324
@JoseV_MD
Jose Villamarin Corrales
3 months
Hi #MedTwitter! I’m Jose Villamarin, a postdoc research fellow at @MayoClinic and an IMG from Ecuador 🇪🇨. Thrilled to be applying for #InternalMedicine #Match2026 I work on patient-centered care, real-world outcomes, and clinical research. Outside the lab, I’m a ⚽ soccer fan
11
17
95
@NeilFlochMD
Neil Floch MD
3 months
Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity
Tweet card summary image
nature.com
Nature Medicine - In an observational study comparing individuals with type 2 diabetes and obesity who underwent metabolic surgery with similar individuals who received GLP-1 receptor agonist...
0
9
26
@TCotterMD
Thomas G. Cotter, MD MS
3 months
Great to see our @NIAAAnews-funded INTEGRATE Study Group work on early liver transplantation in ALD published in @LTxJournal. Privileged to collaborate with leaders @LisaVWMD, @elizabeth_verna, David Goldberg & Jessica Mellinger. Much more to come! 🔗
Tweet card summary image
journals.lww.com
d alcohol use, particularly among patients in early adulthood, and exacerbated by the COVID-19 pandemic, has led to an increased demand for eLT for ALD. Recent studies have demonstrated that eLT can...
0
4
21